A new review published in the World Journal of Pediatrics offers a comprehensive synthesis of how CHD family proteins, which physically reshape DNA to control gene activity, orchestrate the precise sequence of human heart development. By systematically evaluating evidence from human genetics, animal models, and stem-cell systems, the researchers have created a working model that links specific CHD proteins to discrete stages of cardiac formation—a finding that could illuminate the origins of a wide range of congenital heart defects and help prioritize genetic screening.
The heart's development requires thousands of genes to be turned on and off in the right cells at the exact right moment. The new review, published as a DOI:10.1007/s12519-026-01049-y study, reveals a clear division of labor among CHD proteins. CHD7, the gene most frequently mutated in CHARGE syndrome, plays a dominant role in building the heart's early structure. CHD3 and CHD4 act as “identity guardians,” ensuring that heart cells commit to the correct fate during chamber formation. CHD8 appears to regulate later ventricular growth and functional maturation.
“The data show that we cannot treat these proteins as a single, interchangeable group. They have very distinct, stage-specific jobs,” the authors stated. “CHD7 is the key player in the early morphogenetic events, while CHD4 helps lock in the identity of heart cells as they differentiate.” Although these proteins appear to act at different stages—CHD7 early, CHD4 mid, and CHD8 late—the review emphasizes that direct proof of their coordinated action is lacking. To guide future research, the authors propose three testable models: parallel, sequential, and compensatory, each offering a different view of how these remodelers might cooperate or back each other up.
The findings have direct implications for clinical practice. For genetic screening, the study provides a clear priority: CHD7 for outflow-tract defects, CHD4 for chamber-patterning anomalies, and CHD8 for ventricular dysfunction. This prioritization can improve diagnostic efficiency. Therapeutically, while directly targeting remodelers is risky due to their broad expression, identifying their downstream pathways—such as those regulating cardiomyocyte proliferation or metabolism—may offer safer drug targets. Furthermore, future studies combining time-resolved multi-omics and combinatorial genetics could uncover how these proteins coordinate across development, potentially paving the way for precise, temporally controlled epigenetic therapies.
The review was supported by multiple funding sources, including the National Key Research and Development Program of China and the National Natural Science Foundation of China. The original source URL for the study is https://doi.org/10.1007/s12519-026-01049-y.
